Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer;Prosztatadaganatok nagy dózisteljesítményu brachyterápiás "boost" kezelésének dozimetriai értékelése

Magyar Onkologia

Volumn 51, Issue 1, 2007, Pages 31-38

  Fröhlich, Georgina ^a,b   Ágoston, Péter ^b   Lövey, József ^b   Somogyi, András ^b   Fodor, János ^b   Major, Tibor ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; RADIATION DOSE; TREATMENT OUTCOME;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 34548234997     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ágoston P, Major T, Somogyi A, et al. Brachyterápiás boost besugárzás nagy kockázatú, lokalizált prosztatarák kezelésében: Elso hazai tapasztalatok. Magyar Onkológia 48:81-88, 2004
2. Akimoto T, Ito K, Saitoh JI, et al. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63:463-471, 2005
3. Akimoto T, Katoh H, Noda SE, et al. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63:472-478, 2005
4. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315-321, 2000
5. Aström L, Pedersen D, Mercke C, et al. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 74:157- 161, 2005
6. Baltas D, Kolotas C, Geramani K, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 40:515-524, 1998
7. Charra-Brunaud C, Hsu ICJ, Weinberg V, et al. Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high-dose-rate brachytherapy using a computer model. Int J Radiat Oncol Biol Phys 56:586-591, 2003
8. Citrin D, Ning H, Guion P, et al. Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys 61:1267-1275, 2005
9. Crook JM, Potters L, Stock RG, et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 4:186-194, 2005
10. Degera S, Boehmerb D, Roigas J, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 47:441-448, 2005
11. Demanes DJ, Rodriguez RR, Altieri GA. High dose rate prostate brachytherapy: The California Endocurietherapy (CET) Method. Radiother Oncol 57:289-296, 2000
12. Demanes DJ, Rodriguez RR, Schour L, et al. High-doserate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61:1306-1316, 2005
13. Edmundson GK, Rizzo NR, Teahan M, et al. Concurrent treatment planning for outpatient high-dose-rate prostate template implants. Int J Radiat Oncol Biol Phys 27:1215-1223, 1993
14. Edmundson GK, Yan D, Martinez AA. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 33:1257-1263, 1995
15. Fuller DB, Jin H, Koziol JA, et al. CT-ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Brachytherapy 4:207-216, 2005
16. Ghilezan M, Vargas C, Gustafson G, et al. Chronic toxicity profile and biochemical outcome in favorablestage prostate cancer patients undergoing monotherapy with HDR or LDR (Pd103) brachytherapy at William Beaumont Hospital. Int J Radiat Oncol Biol Phys S52: Oral presentation 104, 2004
17. Hoskin PJ. High-dose-rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol 57:285-288, 2000
18. Hsu IC, Lessard E, Weinberg V, et al. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy 3:147-152, 2004
19. Hsu IC, Pickett B, Shinohara K, et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation. Int J Radiat Oncol Biol Phys 46:851-858, 2000
20. Hsu ICJ, Cabrera AR, Weinberg V, et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 4:202-206, 2005
21. Jo J, Hiratsuka J, Fujii T, et al. High-dose-rate Iridium- 192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Urology 64:556-560, 2004
22. Khoo VS. Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy. Clin Oncol 17:560-571, 2005
23. Kini VR, Edmundson GK, Vicini FA, et al. Use of threedimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high-dose-rate prostate brachytherapy implants. Int J Radiat Oncol Biol Phys 43:571-578, 1999
24. Kolkman-Deurloo IKK, Deleye XGJ, Jansen PP, et al. Anatomy based inverse planning in HDR prostate brachytherapy. Radiother Oncol 73:73-77, 2004
25. Kovács G, Pötter R, Loch T, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74:37-148, 2005
26. Mahmoudieh A, Tremblaya C, Beaulieu L, et al. Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study. Radiother Oncol 75:318-324, 2005
27. Martin T, Hey-Koch S, Strassmann G, et al. 3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. Strahlenther Onkol 176:361-367, 2000
28. Martinez AA, Pataki I, Edmundson G, et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 49:61-69, 2001
29. Mate TP, Gottesman JE, Hatton J, et al. High-dose-rate afterloading 192-Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41:525-533, 1998
30. Merrick GS, Butler WM, Wallner KE, et al. The impact of radiation dose to the urethra on brachytherapy-related dysuria. Brachytherapy 4:45-50, 2005
31. Morton GC. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol 17: 219- 227, 2005
32. Nag S, Bice W, Dewyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46:221-230, 2000
33. Nickers P, Lenaerts E, Thissen B, et al. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system? Radiother Oncol 74:131- 136, 2005
34. Nickers P, Thissen B, Jansen N, et al. 192-Ir or 125-I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: A dosimetric point of view. Radiother Oncol 78:47-52, 2006
35. Papagikos MA, deGuzman AF, Rossi PJ, et al. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90? Brachytherapy 4:252- 258, 2005
36. Pinkawa M, Fischedick K, Treusacher P, et al. Dosevolume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer - A phase II study. Radiother Oncol 78:41-46, 2006
37. Sathya JR, Davis IR, Julian JA, et al. Randomized trial comparing Iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 23:1192-1199, 2005
38. Stromberg J, Martinez A, Gonzalez J, et al. Ultrasoundguided high-dose-rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 33:161-171, 1995
39. Sumida I, Shiomi H, Yoshioka V, et al. Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model. Int J Radiat Oncol Biol Phys 64:643-649, 2006
40. Vargas CE, Galalae R, Demanes J, et al. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation. Int J Radiat Oncol Biol Phys 63:1474-1482, 2005
41. Vicini FA, Abner A, Baglan KL, et al. Defining a doseresponse relationship with radiotherapy for prostate cancer: Is more really better? Int J Radiat Oncol Biol Phys 51:1200-1208, 2001
42. Yoshioka Y, Nishimura T, Kamata M, et al. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: A dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization. Radiother Oncol 75:311-317, 2005
43. Yoshioka Y, Nose T, Yoshida K, et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 56:213-220, 2003
44. Yoshioka Y, Nose T, Yoshida K, et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48:675-681, 2000